Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1994
10/13/1994WO1994023048A2 Gibbon ape leukemia virus-based retroviral vectors
10/13/1994WO1994023047A1 Biological control agents containing mollusc toxins
10/13/1994WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II
10/13/1994WO1994023034A2 Variant insulin-like growth factor i receptor subunits and methods for use thereof
10/13/1994WO1994023033A1 Human osteoclast-specific and -related genes
10/13/1994WO1994023032A1 Therapeutic uses of keratinocyte growth factor
10/13/1994WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
10/13/1994WO1994023017A1 A composition useful as additive to a cell culture medium, comprising colostrum and serum
10/13/1994WO1994023016A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
10/13/1994WO1994023014A1 Tumoricide t lymphocytes
10/13/1994WO1994022914A1 Chimeric cytokine receptors in lymphocytes
10/13/1994WO1994022505A1 Tissue equivalents
10/13/1994WO1994022503A1 Two component fibrin glue
10/13/1994WO1994022489A1 Hybrid genes for use in the production of th-independent cytotoxic t cells
10/13/1994WO1994022486A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides
10/13/1994WO1994022482A1 Compositions including heme-containing proteins and methods relating thereto
10/13/1994WO1994022464A1 Urokinase plasminogen activator fragments
10/13/1994WO1994022463A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
10/13/1994WO1994022458A1 Methods for enhancing t-cell effector functions for immunotherapy
10/13/1994WO1994022451A1 Selective regulation of b lymphocyte precursors by hormones
10/13/1994WO1994022286A1 Method of causing somatic hybridization between two species of algae
10/13/1994WO1994017189A3 Protein kinases
10/13/1994WO1994017188A3 Acetyl-coa-carboxylase-gene
10/13/1994WO1994012635A3 Novel seven transmembrane receptors
10/13/1994DE4340129C1 Method for the separation of cellular hybrids by selection using membrane-bound markers
10/13/1994CA2160011A1 Chimeric cytokine receptors in lymphocytes
10/13/1994CA2159898A1 Hybrid genes for use in the production of t h-independent cytotoxic t cells
10/13/1994CA2159637A1 Urokinase plasminogen activator fragments
10/13/1994CA2159595A1 Suppressor of hiv replication and transcription
10/13/1994CA2159471A1 Cell matrix stimulated cell attachment and hemidesmosome assembly
10/13/1994CA2159443A1 Lymphocyte activating agent
10/13/1994CA2159080A1 Human osteoclast-specific and -related genes
10/13/1994CA2158347A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides
10/13/1994CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii
10/13/1994CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
10/12/1994EP0619373A2 Method for cloning and producing the Bg1II restriction endonuclease and modification methylase
10/12/1994EP0619370A1 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body
10/12/1994EP0618976A1 Synthetic dna sequence having enhanced insecticidal activity in maize
10/12/1994EP0618975A1 Dna, dna constructs, cells and plants derived therefrom
10/12/1994EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease
10/12/1994EP0618967A1 Ifn-gamma antagonist cytokine
10/12/1994EP0618964A1 Novel tissue plasminogen activator variants
10/12/1994EP0618930A1 Monoclonal antibody to hiv-2 and uses thereof
10/12/1994EP0618802A1 Synthetic compounds and compositions with enhanced cell binding
10/12/1994EP0494294B1 Bacterial stress proteins
10/12/1994EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE
10/12/1994CN1093406A Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
10/12/1994CN1093404A Tumor necrosis factor prepared by utilizing lymphokine to activate killer cells
10/11/1994US5354946 Gene complex particularly useful for modifying plants such as Cucumis melo and Cucumis melo incorporating said gene complex
10/11/1994US5354847 Chimeric antibody with specificity to human tumor antigen
10/11/1994US5354736 Synthetic compounds and compositions with enhanced cell binding
10/11/1994US5354686 Extracellular matrix protein adherent T cells
10/11/1994US5354678 Production of recombinant adeno-associated virus vectors
10/11/1994US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3
10/11/1994US5354661 Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection
10/11/1994CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies
10/06/1994DE4410136A1 Tumoricidal T lymphocytes
10/05/1994EP0618293A1 Human contactin, a cell adhesion molecule
10/05/1994EP0618292A1 CEA derivatives lacking the Hydrophobic C-terminal domain
10/05/1994EP0618220A1 Method for purifying interleukin-4
10/05/1994EP0617736A1 USE OF $i(BACILLUS THURINGIENSIS) ISOLATES FOR CONTROLLING PESTS IN THE FAMILY APHIDIDAE
10/05/1994EP0602044A4 A cdna clone encoding a human norepineprhine transporter.
10/05/1994EP0576590A4 Response element compositions and assays employing same
10/05/1994EP0434809B1 Method for detecting cirrhosis of the liver
10/04/1994US5352775 Diagnosis, therapy cancer
10/04/1994US5352668 Product and method for improving keratinocyte adhesion to the dermis
10/04/1994US5352664 Thrombin derived polypeptides; compositions and methods for use
10/04/1994US5352587 Genetic engineering
10/04/1994US5352584 Radioimmunoassay or enzyme-linked immunosorbent assay for qunatitative analysis
10/04/1994US5352440 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
09/1994
09/30/1994WO1993019172A1 Methods for producing members of specific binding pairs
09/30/1994CA2131151A1 Methods for producing members of specific binding pairs
09/29/1994WO1994022014A1 Parvovirus receptors and methods of use
09/29/1994WO1994021814A1 Antibodies and assays for determining mutations in the apc gene
09/29/1994WO1994021813A1 Monoclonal antibodies specific for fibroblast growth factor receptors, immunotoxins, and use thereof
09/29/1994WO1994021812A2 Hepatitis b escape mutant specific binding molecules
09/29/1994WO1994021808A1 Process for preparing cancer vaccines
09/29/1994WO1994021806A1 Delivery system controlled through factors associated with hiv and cell
09/29/1994WO1994021799A1 USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES
09/29/1994WO1994021798A1 Stimulation of immune response by viral protein
09/29/1994WO1994021795A1 Novel pesticidal proteins and strains
09/29/1994WO1994021794A1 Dna, dna constructs, cells and plants derived therefrom
09/29/1994WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors
09/29/1994WO1994021787A1 Method for defined deletions of dna
09/29/1994WO1994021784A1 Stromelysin-1 deficient transgenic mice
09/29/1994WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use
09/29/1994WO1994021687A1 A method of detecting rupture of the amniotic membranes in pregant mammals
09/29/1994WO1994021681A1 Growth differentiation factor-8
09/29/1994WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
09/29/1994WO1994021679A1 Inhibitor of vascular endothelial cell growth factor
09/29/1994WO1994021672A1 Novel antimicrobial peptides from bovine neutrophils
09/29/1994WO1994021660A1 Cloned human alpha1c adrenergic receptor
09/29/1994WO1994021291A1 Chlamydia vaccine and process
09/29/1994WO1994021287A1 Peptide coated dendritic cells as immunogens
09/29/1994WO1994021126A1 Nucleic acid coding for a tumor rejection antigen precursor
09/29/1994WO1994021117A1 Method and apparatus for encapsulation of biologically-active substances in cells
09/29/1994WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy
09/29/1994WO1994016094A3 Recombinant anti-vla4 antibody molecules
09/29/1994WO1994013800A3 Mk protein preparation and use in cell culture